Context Partners Fund »

Aegerion Pharmaceuticals Inc note 5.000% 4/0 shares owned by Context Partners Fund

Quarter-by-quarter ownership of Aegerion Pharmaceuticals Inc note 5.000% 4/0 shares owned by Context Partners Fund from 13F filings

Historical chart of Context Partners Fund investment in Aegerion Pharmaceuticals Inc note 5.000% 4/0

Tip: Access up to 7 years of quarterly data

All positions including Aegerion Pharmaceuticals Inc note 5.000% 4/0 held by Context Partners Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aegerion Pharmaceuticals Inc note 5.000% 4/0 by Context Partners Fund

Quarter filed Position value Share count Share price at filing
2020-09-30 $564k 472k 1.19

More positions owned by Context Partners Fund

8X8 Note 0.500% 2/0 (Principal)
Sea Debt 2.375%12/0 (Principal)
Veoneer Incorporated Note 4.000% 6/0 (Principal)
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
Amag Pharmaceuticals Note 3.250% 6/0 (Principal)
Cf Finance Acquisition Corp Unit 08/01/2027
Churchill Capital Corp Iv Unit 99/99/9999
Nanthealth Note 5.500%12/1 (Principal)
Infinera Corporation Note 2.125% 9/0 (Principal)
Pra Group Note 3.500% 6/0 (Principal)
Flexion Therapeutics Note 3.375% 5/0 (Principal)
Navsight Hldgs Unit 99/99/9999
Retrophin Note 2.500% 9/1 (Principal)
Seacor Holdings Note 2.500%12/1 (Principal)
Iqiyi Debt 3.750%12/0 (Principal)

View all positions for Context Partners Fund